Anders Lundin

Anders Lundin is an experienced financial leader with over 30 years of expertise in international organizations across the automotive, telecom, medical device, and life sciences sectors. They currently serve as an Interim CFO at Airsonett AB and have held various roles, including CFO and IR at Oasmia Pharmaceutical AB and Q-linea. Anders has a strong track record in driving revenue growth, cost efficiencies, and successful IPO preparations. They hold a Bachelor of Business Administration from Uppsala University and have completed an Executive Education program in Management and Corporate Governance. Additionally, Anders is an active Board Member at EMPE Diagnostics.